These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22458506)

  • 21. Peptidomimetic inhibitors of cathepsin K.
    Black WC
    Curr Top Med Chem; 2010; 10(7):745-51. PubMed ID: 20337585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cruzain : the path from target validation to the clinic.
    Sajid M; Robertson SA; Brinen LS; McKerrow JH
    Adv Exp Med Biol; 2011; 712():100-15. PubMed ID: 21660661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping the S1 and S1' subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents.
    Cianni L; Lemke C; Gilberg E; Feldmann C; Rosini F; Rocho FDR; Ribeiro JFR; Tezuka DY; Lopes CD; de Albuquerque S; Bajorath J; Laufer S; Leitão A; Gütschow M; Montanari CA
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0007755. PubMed ID: 32163418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteine peptidase inhibitors in trypanosomatid parasites.
    Lima AP; Reis FC; Costa TF
    Curr Med Chem; 2013; 20(25):3152-73. PubMed ID: 23514421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of trypanocidal activity of combinations of anti-sleeping sickness drugs with cysteine protease inhibitors.
    Steverding D
    Exp Parasitol; 2015; 151-152():28-33. PubMed ID: 25662707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria.
    Di Chio C; Starvaggi J; Totaro N; Previti S; Natale B; Cosconati S; Bogacz M; Schirmeister T; Legac J; Rosenthal PJ; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach.
    Hernández Alvarez L; Barreto Gomes DE; Hernández González JE; Pascutti PG
    PLoS One; 2019; 14(1):e0211227. PubMed ID: 30682119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain.
    McShan D; Kathman S; Lowe B; Xu Z; Zhan J; Statsyuk A; Ogungbe IV
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4509-12. PubMed ID: 26342866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases.
    Li L; Chenna BC; Yang KS; Cole TR; Goodall ZT; Giardini M; Moghadamchargari Z; Hernandez EA; Gomez J; Calvet CM; Bernatchez JA; Mellott DM; Zhu J; Rademacher A; Thomas D; Blankenship LR; Drelich A; Laganowsky A; Tseng CK; Liu WR; Wand AJ; Cruz-Reyes J; Siqueira-Neto JL; Meek TD
    J Med Chem; 2021 Aug; 64(15):11267-11287. PubMed ID: 34288674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain.
    Du X; Guo C; Hansell E; Doyle PS; Caffrey CR; Holler TP; McKerrow JH; Cohen FE
    J Med Chem; 2002 Jun; 45(13):2695-707. PubMed ID: 12061873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease.
    Beaulieu C; Isabel E; Fortier A; Massé F; Mellon C; Méthot N; Ndao M; Nicoll-Griffith D; Lee D; Park H; Black WC
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7444-9. PubMed ID: 21041084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense.
    Di Chio C; Previti S; Amendola G; Ravichandran R; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M; Ettari R
    Eur J Med Chem; 2022 Jun; 236():114328. PubMed ID: 35385806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved trypanocidal activities of cathepsin L inhibitors.
    Nkemgu NJ; Grande R; Hansell E; McKerrow JH; Caffrey CR; Steverding D
    Int J Antimicrob Agents; 2003 Aug; 22(2):155-9. PubMed ID: 12927956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.
    Doyle PS; Zhou YM; Engel JC; McKerrow JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3932-9. PubMed ID: 17698625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity.
    Chenna BC; Li L; Mellott DM; Zhai X; Siqueira-Neto JL; Calvet Alvarez C; Bernatchez JA; Desormeaux E; Alvarez Hernandez E; Gomez J; McKerrow JH; Cruz-Reyes J; Meek TD
    J Med Chem; 2020 Mar; 63(6):3298-3316. PubMed ID: 32125159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases.
    Silva LR; Guimarães AS; do Nascimento J; do Santos Nascimento IJ; da Silva EB; McKerrow JH; Cardoso SH; da Silva-Júnior EF
    Bioorg Med Chem; 2021 Jul; 41():116213. PubMed ID: 33992862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cysteine proteinases of trypanosome parasites: novel targets for chemotherapy.
    Caffrey CR; Scory S; Steverding D
    Curr Drug Targets; 2000 Sep; 1(2):155-62. PubMed ID: 11465068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies.
    Jung S; Fuchs N; Johe P; Wagner A; Diehl E; Yuliani T; Zimmer C; Barthels F; Zimmermann RA; Klein P; Waigel W; Meyr J; Opatz T; Tenzer S; Distler U; Räder HJ; Kersten C; Engels B; Hellmich UA; Klein J; Schirmeister T
    J Med Chem; 2021 Aug; 64(16):12322-12358. PubMed ID: 34378914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei brucei.
    Troeberg L; Chen X; Flaherty TM; Morty RE; Cheng M; Hua H; Springer C; McKerrow JH; Kenyon GL; Lonsdale-Eccles JD; Coetzer TH; Cohen FE
    Mol Med; 2000 Aug; 6(8):660-9. PubMed ID: 11055585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.